• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于对比增强计算机断层扫描和患者特征对双表型和非双表型肝细胞癌进行鉴别

Differentiation of dual- and non-dual-phenotype hepatocellular carcinoma based on contrast-enhanced computed tomography and patient characteristics.

作者信息

Qin Yunying, Zhang Siyi, Huang Xiangyang, Luo Ningbin, Su Danke

机构信息

Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.

Guangxi Key Clinical Specialty (Medical Imaging Department), Nanning, China.

出版信息

Quant Imaging Med Surg. 2025 Aug 1;15(8):7146-7154. doi: 10.21037/qims-24-1168. Epub 2025 Jul 23.

DOI:10.21037/qims-24-1168
PMID:40785933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12332666/
Abstract

BACKGROUND

Dual-phenotype hepatocellular carcinoma (DPHCC) is associated with a higher risk of recurrence, but little is known about its clinicodemographic characteristics or imaging features. This study aimed to assess whether contrast-enhanced computed tomography (CECT) and patient characteristics can facilitate preoperative differentiation of DPHCC and non-DPHCC.

METHODS

Features on CECT images and clinicodemographic characteristics were retrospectively analyzed from a consecutive series of hepatocellular carcinoma (HCC) patients between January 2020 and December 2020. Disease was confirmed based on surgical pathology, and CECT was performed within four weeks before surgery. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for DPHCC, and an imaging model based on CECT features and a combined model based on clinicodemographic characteristics and CECT features were constructed, respectively. Delong's test was used for comparison of the area under the curve (AUC) values between the two models. Kaplan-Meier survival analysis was used to assess overall survival (OS) in DPHCC and non-DPHCC groups.

RESULTS

A total of 29 patients with DPHCC and 140 with non-DPHCC were included in this study. DPHCC was significantly more prevalent among female patients and less prevalent among those infected with hepatitis B virus (HBV). CECT associated DPHCC with rim arterial phase hyperenhancement (APHE) and peripheral washout, whereas it associated non-DPHCC with non-rim APHE and non-peripheral washout. Multivariate logistic regression identified one independent CECT feature of DPHCC: rim APHE [odds ratio (OR) 11.040, 95% confidence interval (CI): 1.98-63.532]. The imaging model was constructed based on rim APHE-predicted DPHCC with an AUC of 0.562 (95% CI: 0.439-0.684). Multivariate logistic regression identified three independent clinicodemographic characteristics and CECT features of DPHCC: female sex (OR 4.519, 95% CI: 1.529-13.357), infection with HBV (OR 0.234, 95% CI: 0.084-0.654) and rim APHE (OR 15.016, 95% CI: 2.335-96.585). The combined model was constructed based on three independent predictors of DPHCC with an AUC of 0.716 (95% CI: 0.603-0.829). Delong's test showed that the AUC of the combined model was higher than that of the imaging model, and the difference was statistically significant (Z=3.207, P<0.05). The OS rates of the patients in the DPHCC and non-DPHCC groups were 68.7% and 77.2%, respectively. Kaplan-Meier survival analysis showed no statistical difference in OS rates between groups (P=0.362).

CONCLUSIONS

The combined model established based on female sex, infection with HBV, and rim APHE by CECT can facilitate preoperative differentiation of DPHCC and non-DPHCC. DPHCC is more likely to cause death than non-DPHCC, suggesting that active postoperative management of patients with DPHCC is required.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/89ab5a2926e2/qims-15-08-7146-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/114868018477/qims-15-08-7146-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/99286c9f0bee/qims-15-08-7146-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/2c318b06b899/qims-15-08-7146-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/1b883d887952/qims-15-08-7146-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/89ab5a2926e2/qims-15-08-7146-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/114868018477/qims-15-08-7146-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/99286c9f0bee/qims-15-08-7146-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/2c318b06b899/qims-15-08-7146-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/1b883d887952/qims-15-08-7146-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12332666/89ab5a2926e2/qims-15-08-7146-f5.jpg
摘要

背景

双表型肝细胞癌(DPHCC)与较高的复发风险相关,但对其临床人口统计学特征或影像学特征知之甚少。本研究旨在评估对比增强计算机断层扫描(CECT)和患者特征是否有助于术前鉴别DPHCC和非DPHCC。

方法

回顾性分析2020年1月至2020年12月连续收治的一系列肝细胞癌(HCC)患者的CECT图像特征和临床人口统计学特征。根据手术病理确诊疾病,且在手术前四周内进行CECT检查。进行单因素和多因素逻辑回归分析以确定DPHCC的独立危险因素,并分别构建基于CECT特征的影像模型和基于临床人口统计学特征及CECT特征的联合模型。使用德龙检验比较两个模型的曲线下面积(AUC)值。采用Kaplan-Meier生存分析评估DPHCC组和非DPHCC组的总生存期(OS)。

结果

本研究共纳入29例DPHCC患者和140例非DPHCC患者。DPHCC在女性患者中更为常见,而在感染乙型肝炎病毒(HBV)的患者中较少见。CECT显示DPHCC表现为边缘动脉期强化(APHE)和周边廓清,而非DPHCC表现为非边缘APHE和非周边廓清。多因素逻辑回归确定了DPHCC的一个独立CECT特征:边缘APHE[比值比(OR)11.040,95%置信区间(CI):1.98 - 63.532]。基于边缘APHE构建的影像模型预测DPHCC的AUC为0.562(95%CI:0.439 - 0.684)。多因素逻辑回归确定了DPHCC的三个独立临床人口统计学特征和CECT特征:女性(OR 4.519,95%CI:1.529 - 13.357)、HBV感染(OR 0.234,95%CI:0.084 - 0.654)和边缘APHE(OR 15.016,95%CI:2.335 - 96.585)。基于DPHCC的三个独立预测因素构建的联合模型的AUC为0.716(95%CI:0.603 - 0.829)。德龙检验显示联合模型的AUC高于影像模型,差异具有统计学意义(Z = 3.207,P < 0.05)。DPHCC组和非DPHCC组患者的OS率分别为68.7%和7与7.2%。Kaplan-Meier生存分析显示两组之间的OS率无统计学差异(P = 0.362)。

结论

基于女性、HBV感染和CECT边缘APHE建立的联合模型有助于术前鉴别DPHCC和非DPHCC。DPHCC比非DPHCC更易导致死亡,提示需要对DPHCC患者进行积极的术后管理。

相似文献

1
Differentiation of dual- and non-dual-phenotype hepatocellular carcinoma based on contrast-enhanced computed tomography and patient characteristics.基于对比增强计算机断层扫描和患者特征对双表型和非双表型肝细胞癌进行鉴别
Quant Imaging Med Surg. 2025 Aug 1;15(8):7146-7154. doi: 10.21037/qims-24-1168. Epub 2025 Jul 23.
2
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
3
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Preoperative Prediction of a Rare and Highly Aggressive Subtype of Hepatocellular Carcinoma Based on Multimodal Imaging and Clinical Indicators.基于多模态成像和临床指标对一种罕见且侵袭性强的肝细胞癌亚型进行术前预测
J Hepatocell Carcinoma. 2025 Jun 30;12:1253-1266. doi: 10.2147/JHC.S533963. eCollection 2025.
6
[Study of a nomogram model of gadoxetate disodium-enhanced magnetic resonance imaging for the preoperative diagnosis of proliferative hepatocellular carcinoma and its value].钆塞酸二钠增强磁共振成像预测增殖型肝细胞癌术前诊断的列线图模型及其价值研究
Zhonghua Gan Zang Bing Za Zhi. 2025 Mar 20;33(3):227-236. doi: 10.3760/cma.j.cn501113-20240509-00246.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

本文引用的文献

1
Prediction of dual-phenotype hepatocellular carcinoma based on ultrasound and contrast enhanced ultrasound - a preliminary study.基于超声及超声造影对双表型肝细胞癌的预测——一项初步研究
Med Ultrason. 2025 Jun 16;27(2):135-142. doi: 10.11152/mu-4466. Epub 2024 Dec 19.
2
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.肝细胞-胆管细胞癌:生物学、诊断与管理
Liver Cancer. 2023 Apr 24;13(1):6-28. doi: 10.1159/000530700. eCollection 2024 Feb.
3
A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.
基于钆塞酸二钠增强磁共振成像(使用Li-RADS v2018)及其他影像特征的多变量模型用于术前预测双表型肝细胞癌。
Radiol Med. 2023 Nov;128(11):1333-1346. doi: 10.1007/s11547-023-01715-5. Epub 2023 Sep 23.
4
Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.MRI 特征对双表型肝细胞癌的诊断价值:一项初步研究。
J Digit Imaging. 2023 Dec;36(6):2554-2566. doi: 10.1007/s10278-023-00888-9. Epub 2023 Aug 14.
5
Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.使用增强MRI放射组学模型对双表型肝细胞癌进行术前诊断
J Magn Reson Imaging. 2023 Apr;57(4):1185-1196. doi: 10.1002/jmri.28391. Epub 2022 Aug 17.
6
A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.一种用于预测肝细胞癌切除术后肝衰竭的术前肝功能成像评分。
Eur Radiol. 2022 Aug;32(8):5623-5632. doi: 10.1007/s00330-022-08656-z. Epub 2022 Mar 16.
7
Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis.早期肝细胞癌肝切除术后复发的临床特征及复发患者的长期生存结果:一项多机构分析
Ann Surg Oncol. 2022 Feb 22. doi: 10.1245/s10434-022-11454-y.
8
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.美国肝内胆管细胞癌与肝细胞癌的临床特征和结局比较。
Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25.
9
Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.肝细胞癌的诊断与治疗进展
Gastroenterol Hepatol (N Y). 2020 Oct;16(10):506-516.
10
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.英国原发性肝癌:按亚型、性别和地区划分的发病率、基于发病率的死亡率及生存率
JHEP Rep. 2021 Jan 19;3(2):100232. doi: 10.1016/j.jhepr.2021.100232. eCollection 2021 Apr.